The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome

Cancer Research

Volumn 65, Issue 6, 2005, Pages 2330-2336

  Bauskin, Asne R ^a,d   Brown, David A ^a   Junankar, Simon ^a   Rasiah, Krishan K ^b   Eggleton, Sarah ^b   Hunter, Mark ^a   Liu, Tao ^a   Smith, Dave ^a   Kuffner, Tamara ^a   Pankhurst, Greg J ^a   Johnen, Heiko ^a   Russell, Pamela J ^c   Barret, Wade ^b   Stricker, Phillip D ^b   Grygiel, John J ^b   Kench, James G ^b   Henshall, Susan M ^b   Sutherland, Robert L ^b   Breit, Samuel N ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MACROPHAGE INHIBITORY CYTOKINE 1; PROTEIN; PROTEIN PROMIC 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RELAPSE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLEASON SCORE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MODEL; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN SECRETION; TERMINAL SEQUENCE; TREATMENT OUTCOME;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; DOGS; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN PRECURSORS; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 20144389237     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3827     Document Type: Article

References (34)

1. Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily cluster. Proc Natl Acad Sci U S A 1997;94:11514-9.
2. Strelau J, Bottner M, Linger P, et al. GDF-15/MIC-1 a novel member of the TGF-β superfamily. J Neural Transm Suppl 2000;60:273-6.
3. Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang H-P, Breit SN. MIC-1 is a novel TGF-b superfamily cytokine associated with macrophage activation. J Leukoc Biol 1999;65:2-5.
4. Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ. Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury. Mol Cell Biol 2000;20:3742-51.
5. Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
6. Buckhaults P, Rago C, St Croix B, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61:6996-7001.
7. Welsh JB, Sapinoso LM, Kern SG, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci U S A 2003;100:3410-5.
8. Liu T, Bauskin AR, Zaunders J, et al. MIC-1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003;63:5034-40.
9. Brown DA, Ward RL, Buckhaults P, et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003;9:2642-50.
10. Koopmann J, Buckhaults P, Brown DA, et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004;10:2386-92.
11. Li PX, Wong J, Ayed A, et al. Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000;75:20127-35.
12. Tan M, Wang Y, Guan K, Sun Y. PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc Natl Acad Sci U S A 2000;97:109-14.
13. Graichen R, Liu D, Sun Y, Lee KO, Lobie PE. Autocrine human growth hormone inhibits placental transforming growth factor-β gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells. J Biol Chem 2002;277:26662-72.
14. Albertoni M, Shaw PH, Nozaki M, et al. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 2002;21:4212-9.
15. Bauskin AR, Zhang H-P, Fairlie WD, et al. The propeptide of MIC-1, a TGF-β superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J 2000;19:2212-20.
16. Fairlie WD, Zhang H-P, Wu WM, et al. The propeptide of the TGF-β superfamily member, MIC-1, is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem 2001;276:16911-8.
17. Moore AG, Brown DA, Fairlie WD, et al. The transforming growth factor-b superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 2000;85:4781-8.
18. Brown DA, Breit SN, Buring J, et al. Concentration in plasma of MIC-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 2002;359:2159-63.
19. Valenzuela SM, Martin DK, Por SB, et al. Molecular cloning and expression of a chloride ion channel of cell nuclei. J Biol Chem 1997;272:12575-82.
20. Goerges AL, Nugent MA. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 2003;278:19518-25.
21. Quinn DI, Henshall SM, Haynes AM, et al. Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models. J Clin Oncol 2001;19:3692-705.
22. Henshall SM, Afar DE, Rasiah KK, et al. Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene 2003;22:6005-12.
23. Seidah NG, Prat A, Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem 2002;38:79-94.
24. Taylor NA, Van De Ven WJ, Creemers JW. Curbing activation: proprotein convertases in homeostasis and pathology. FASEB J 2003;17:1215-27.
25. Tsuji A, Sakurai K, Kiyokage E, et al. Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Biochim Biophys Acta 2003;1645:95-104.
26. Bostwick DG. Prostatic intraepithelial neoplasia (PIN). Urology 1989;34:16-22.
27. Horvath LG, Henshall SM, Kench JG, et al. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 2004;59:234-42.
28. DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003;361:955-64.
29. Kannan K, Amariglio N, Rechavi G, Givol D. Profile of gene expression regulated by induced p53: connection to the TGF-β family. FEBS Lett 2000;470:77-82.
30. Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT. Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2003;2:1023-9.
31. Baek SJ, Wilson LC, Lee CH, Eling TE. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther 2002;301:1126-31.
32. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. Expression of NAG-1, a transforming growth factor β superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 2004;279:6883-92.
33. Lindmark F, Zheng SL, Wiklund F, et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 2004;96:1248-54.
34. Knappick A, Pluckthun A. An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. BioTechniques 1994;17:754-61.